melphalan
Showing 1 - 25 of 510
Multiple Myeloma Trial (Melphalan and Treosulfan, Melphalan)
Not yet recruiting
- Multiple Myeloma
- Melphalan and Treosulfan
- Melphalan
- (no location specified)
Dec 5, 2022
Lymphoma Trial in New York (rituximab, bendamustine, melphalan)
Active, not recruiting
- Lymphoma
- rituximab
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 10, 2023
Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Frankfurt, Hannover, Jena (Delcath Hepatic Delivery System,
Terminated
- Hepatocellular Carcinoma
- Intrahepatic Cholangiocarcinoma
- Delcath Hepatic Delivery System
- Melphalan
-
Frankfurt, Germany
- +2 more
Oct 13, 2022
Multiple Myeloma Trial in Saint Louis (Uproleselan, Placebo, Melphalan)
Completed
- Multiple Myeloma
- Uproleselan
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 22, 2022
Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)
Not yet recruiting
- Uveal Melanoma
- Metastatic Cutaneous Melanoma
- Autologous Tumor Infiltrating Lymphocytes
- +2 more
- (no location specified)
Jun 5, 2023
Multiple Myeloma Trial in Tampa (Selinexor, Melphalan, Dexamethasone)
Completed
- Multiple Myeloma
- Selinexor
- +4 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 2, 2022
Multiple Myeloma Trial in Seattle (Allopurinol, Carmustine, Etoposide)
Recruiting
- Multiple Myeloma
- Allopurinol
- +4 more
-
Seattle, WashingtonSwedish Cancer Institute
Jun 21, 2022
Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in
Not yet recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
- Fludarabine
- +2 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Aug 31, 2023
Diffuse Large B Cell Lymphoma Trial (Venetoclax, Carmustine, Cytarabine)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- Venetoclax
- +5 more
- (no location specified)
May 9, 2023
Multiple Myeloma, Newly Diagnosed Patients Trial in Torino (Melphalan, Lenalidomide, Prednisone)
Active, not recruiting
- Multiple Myeloma
- Newly Diagnosed Patients
- Melphalan
- +2 more
-
Torino, ItalyDivision of Hematology, AOU Città della Salute e della Scienza d
Mar 24, 2022
Retinoblastoma Trial in Saint Louis (Melphalan)
Active, not recruiting
- Retinoblastoma
- Melphalan
-
Saint Louis, MissouriWashington University School of Medicine (Saint Louis Children's
Jan 6, 2023
T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)
Terminated
- T-cell Non-Hodgkin Lymphoma
- Cyclophosphamide
- +12 more
-
Boston, Massachusetts
- +1 more
Jan 26, 2023
Multiple Myeloma Trial in Washington, Hackensack (Melphalan, Bortezomib)
Active, not recruiting
- Multiple Myeloma
- Melphalan
- Bortezomib
-
Washington, District of Columbia
- +1 more
May 6, 2022
Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)
Active, not recruiting
- Primary Systemic Amyloidosis
- Light Chain Deposition Disease
- bortezomib
- +6 more
-
Denver, Colorado
- +6 more
Aug 24, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 12, 2023
Multiple Myeloma Trial in Torino (Cyclophosphamide, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Cyclophosphamide
- +3 more
-
Torino, ItalyDivision of Hematology, Molinette Hospital
Apr 6, 2022
Leukemia, MDS Trial in Duarte (drug, procedure, radiation)
Active, not recruiting
- Leukemia
- Myelodysplastic Syndromes
- fludarabine phosphate
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total
Active, not recruiting
- Acute Myeloid Leukemia
- +17 more
- Fludarabine
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023
Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)
Active, not recruiting
- Plasma Cell Leukemia
- Plasma Cell Myeloma
- Autologous Hematopoietic Stem Cell Transplantation
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Bilateral Retinoblastoma, Childhood Intraocular Retinoblastoma, Unilateral Retinoblastoma Trial (Biospecimen Collection,
Not yet recruiting
- Bilateral Retinoblastoma
- +2 more
- Biospecimen Collection
- +6 more
- (no location specified)
Aug 17, 2022
Leukemia Trial in Cleveland (Melphalan, Thiotepa, Fludarabine)
Recruiting
- Leukemia
- Melphalan
- +3 more
-
Cleveland, OhioUniversity Hospitals Seidman Cancer Center, Case Comprehensive C
Jan 24, 2022
Multiple Myeloma, Amyloidosis Trial in New York (device, drug, procedure)
Active, not recruiting
- Multiple Myeloma
- Amyloidosis
- Melphalan
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)
Recruiting
- Plasma Cell Myeloma
- Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 27, 2022
Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)
Active, not recruiting
- Plasma Cell Leukemia
- +3 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
Multiple Myeloma, Relapsed, Multiple Myeloma, Refractory to Standard Treatment Trial in Chicago (radiation, drug, procedure)
Completed
- Multiple Myeloma, Relapsed
- Multiple Myeloma, Refractory to Standard Treatment
- Total Marrow Irradiation
- +3 more
-
Chicago, IllinoisUniversity of Illinois Cancer Center
Nov 20, 2021